The top federal drug researcher says even she is reluctant to conduct studies on Schedule I drugs like marijuana because of the “cumbersome” rules that scientists face when investigating them. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), made the comments during a Wednesday forum moderated by The Hill and sponsored by … Continue reading Top Federal Drug Official Personally Hesitates To Study Marijuana Because Of Schedule I Research Barriers